Intelligent Bio Solutions (INBS) Operating Expenses (2019 - 2024)
Intelligent Bio Solutions has reported Operating Expenses over the past 6 years, most recently at $3.2 million for Q1 2024.
- Quarterly results put Operating Expenses at $3.2 million for Q1 2024, down 51.96% from a year ago — trailing twelve months through Mar 2024 was $11.2 million (down 13.85% YoY), and the annual figure for FY2024 was $1.7 million, down 87.64%.
- Operating Expenses for Q1 2024 was $3.2 million at Intelligent Bio Solutions, up from $2.3 million in the prior quarter.
- Over the last five years, Operating Expenses for INBS hit a ceiling of $6.7 million in Q1 2023 and a floor of $27291.0 in Q1 2020.
- Median Operating Expenses over the past 5 years was $2.3 million (2023), compared with a mean of $2.3 million.
- Biggest five-year swings in Operating Expenses: skyrocketed 11533.16% in 2021 and later plummeted 51.96% in 2024.
- Intelligent Bio Solutions' Operating Expenses stood at $1.2 million in 2020, then soared by 203.61% to $3.6 million in 2021, then fell by 27.43% to $2.6 million in 2022, then decreased by 11.37% to $2.3 million in 2023, then skyrocketed by 37.22% to $3.2 million in 2024.
- The last three reported values for Operating Expenses were $3.2 million (Q1 2024), $2.3 million (Q4 2023), and $2.9 million (Q3 2023) per Business Quant data.